Inactivated rotavirus vaccine - Beijing Zhifei Lvzhu Biopharmaceutical
Latest Information Update: 26 Apr 2024
At a glance
- Originator Beijing Zhifei Lvzhu Biopharmaceutical
- Class Rotavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Rotavirus infections
Most Recent Events
- 03 Aug 2021 Phase-I clinical trials in Rotavirus infections (In infants, In adolescents, In children, In adults, Prevention) in China (Parenteral) (NCT06350058)